Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05463406Not ApplicableCompleted

Procalcitonin and Lung Ultrasonography Guided Antibiotherapy in Emergency Departments

Role: collaborator

NCT06563362Phase 2Recruiting

Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma

Role: collaborator

NCT06921681Not ApplicableRecruiting

Ultrasound-guided Cryobiopsy of Mediastinal/Hilar Lymph Nodes

Role: collaborator

NCT03921346Not ApplicableCompleted

Reducing Prehospital Medication Errors & Time to Drug Delivery by EMS During Simulated Pediatric CPR

Role: collaborator

NCT05415969Completed

CKD-aP Among Adults on Dialysis in Switzerland

Role: collaborator

All 5 trials loaded